Stock screenerAll disclosures →
EDGAR →
TNGX
Conviction 75HealthcareScan · Mon, Aug 10, 2026TNGX$27.65+2.14%
ResistanceSupportVol 14Insider sell2
2
Vol MA14 2.34M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price27.65
Change+2.14%
Gap-0.70%
Rel volume1.49×
Avg volume2.31M
Avg $ vol64.12M
SMA 2027.89
SMA 5028.32
SMA 20018.04
Price vs 50-2.35%
Price vs 200+53.30%
MA stackmixed
50/200 cross—
Supertrendup · 25.61
RSI (14)48
MACD hist0.01
MACD crossbull · 3d
Stoch %K / %D47 / 52
ADX (14)14
+DI / −DI18 / 19
RSI divergence—
MACD divergence—
ATR %+6.79%
ADR %6.07%
52w high32.90
52w low6.36
From 52w high-15.96%
Above 52w low+334.75%
New 52w highNo
SqueezeOn · 3d
Bollinger width16.18%
%B0.45
Donchian pos44.40%
Donchian high30.56
Donchian low25.33
AVWAP (52w high)29.31
vs AVWAP high-5.67%
AVWAP (52w low)17.63
vs AVWAP low+56.85%
OBV trendFlat
Chaikin MF (20)0.04
Today vs 20d1.49×
Avg vol (14d)2.34M
Avg vol (20d)2.31M
Avg $ vol (20d)64.12M
Market cap4B
RS 3m (vs SPY)+9.59%
RS 6m (vs SPY)+112.41%
RS line new highNo
Trend template7/8
Technical rank67.0
1 week+1.62%
1 month-10.98%
3 months+20.11%
6 months+121.02%
1 year+318.31%
YTD+209.63%
P/E-39.37
P/B10.22
P/S64.11
P/FCF-28.58
EPS-0.8700
Div yield—
ROE-25.95%
ROA-23.31%
Debt/Eq—
Current27.38
EV/EBITDA—
Gross margin—
Net margin-162.85%
Rev growth48.29%
EPS growth22.03%
Price target42.67
Target upside54.32%
Analyst ratingBuy
Institutional120.17%
Ent. value3.84B
Revenue0
Net income-45.51M
Gross profit—
Free cash flow-139.93M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out144.65M
Employees137
ListedWed, Aug 11, 2021
Free float128.95M
Float %89.4%
Short interest42.72M
Days to cover15.3d
Short volume41.0%
Squeeze score73 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.32 vs −$0.32
Last surprise0.0% beat
Setup gradeA
Conviction75 / 100
Pattern quality—
Tech rank67.0 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance33.96
Support25.64
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in TNGX
No recent disclosed trades by Congress in TNGX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in TNGX · 7 buys · 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Crystal Adam President, R&D · Common Stock · 2026-08-03 | Exercise | 27K | $140K | 2026-08-03 | 2026-08-05 |
Crystal Adam President, R&D · Common Stock · 2026-08-03 | Sell | 5.27K | $141K | 2026-08-03 | 2026-08-05 |
Crystal Adam President, R&D · Common Stock · 2026-08-03 | Sell | 21.73K | $594K | 2026-08-03 | 2026-08-05 |
Crystal Adam President, R&D · Stock Option (Right to Buy) · 2026-08-03 | Exercise | 27K | — | 2026-08-03 | 2026-08-05 |
Lee Sung Director · Common Stock · 2026-06-05 | Grant | 570 | $0 | 2026-06-05 | 2026-06-08 |
Ketchum John B Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 25K | $0 | 2026-06-05 | 2026-06-08 |
Ketchum John B Director · Common Stock · 2026-06-05 | Grant | 4K | $0 | 2026-06-05 | 2026-06-08 |
Rothenberg Mace Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 25K | $0 | 2026-06-05 | 2026-06-08 |
Lee Sung Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 3.57K | $0 | 2026-06-05 | 2026-06-08 |
Calhoun Lesley Ann Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 25K | $0 | 2026-06-05 | 2026-06-08 |
SEC filings
EDGAR filings in TNGX · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.